Announced Wed, 15 Jul · 18:50 IST
Quarterly share capital audit report submitted for Q1 FY27
Compliance View source PDF
MEDANTA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-1.9%1-day move
₹1342.00
prior close
₹1343.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.5-0.5-0.9-0.7-1.9-0.1+0.1+0.8+2.6+5.1————
Up moveDown movePending
AI summary
Global Health (Medanta) filed the quarterly share capital audit for Q1 FY27 (ended June 30, 2026). Issued capital is about 26.89 crore shares of Rs 2 face value. 99.99 percent shares are listed and almost all are in demat form (93.26 percent NSDL, 6.73 percent CDSL). A gap of 4,000 shares exists due to ESOP allotments under the GHL LTIP Scheme 2024 on June 24, 2026, pending listing approval at quarter end. Listing approval came on July 9, 2026.
Likely market impact
Routine regulatory filing with no material impact. Confirms 4,000 ESOP shares allotted during the quarter are now fully listed.